News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Here's Why The Best Is Yet To Come For EXACT Sciences (EXAS)



8/2/2017 6:32:10 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Millions of Americans forego getting tested for colon cancer; however, a new colon cancer test from Exact Sciences (NASDAQ:EXAS) is changing that, and as a result, patients are catching their cancer sooner. The simple test is resonating with aging baby boomers who might otherwise skip testing, and since guidelines call for testing everyone between age 50 to 74, there's still a lot of untapped market opportunity that could reward Exact Sciences' investors.

Read at Motley Fool


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES